Collectively, our findings position Erk1/2 as a nodal regulator orchestrating the tripartite interplay between ferroptosis susceptibility, Nrf1/2‐mediated redox adaptation and mitochondrial plasticity in HCC. This evidence concerns the gene NRF1 and hepatocellular carcinoma.